Better outcomes for more patients, faster

 Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.


Our commitment to research and development means we can bring to the market integrated solutions in diagnostic testing, laboratory efficiency, healthcare digitalisation and decision support tools and software. Our products deliver increasingly precise information to help save lives, prevent or control the risk of infection and monitor treatment effectiveness.

Roche is an established and important contributor to the Hungarian economy. We invest …………………. of our domestic revenue back into the country each year.

In 2019 this generated total contribution to Hungary’s GDP totaling ………. bn HUF - or approximately …….% of the total GDP. This year Roche involved nearly ……… Hungarian patients in clinical trials across 150 sites. In total, we conducted 82 research studies across six therapeutic areas being oncology, immunology/inflammatory disease, neurology/psychiatry, pulmonology, hematology/nephrology, and ophthalmology. The majority of our trails are still in oncology, but we are also entering more into neurology and ophthalmology areas as well. Most importantly, Roche made payments totaling to HUF …… (USD …… ) million and generated a cost savings of HUF …… (USD ……) million for the Hungarian drug budget.

Our aim  is to ensure that the screening, diagnosis, treatment and even prevention of diseases will more quickly and effectively transform the lives of people everywhere - ensuring the right treatment for the right patient at the right time.

We believe that addressing the big challenges in healthcare will require better integration, use and sharing of data, and that advances in more personalized and patient centered care will provide real opportunities to improve patient outcomes and increase system efficiency. Our mission is to close the gap between the Hungarian and European patients’ outcomes by building partnerships with Hungarian patients and the healthcare system’s stakeholders, utilizing Roche’s portfolio and beyond.

A budapesti szolgáltatóközpont 26 nyelven nyújt pénzügyi, HR és informatikai szolgáltatásokat a világ számos Roche leányvállalata számára. Szintén Magyarországon található az Európai Törzskönyvező Központ, amely részt vesz a Roche törzskönyvezési eljárásokkal kapcsolatos adminisztratív feladataiban és koordinálja az EU nemzeti hatóságokhoz történő törzskönyvezési beadásokat. Emellett 2013-tól fogva Magyarország kormánya is háromoldalú stratégiai megállapodásban áll a Roche Diagnostics Ltd.-vel és a 77 Elektronika Kft.-vel.